Humira 40mg as an Effective Treatment of Psoriasis Arthritis
Humira, also known as adalimumab, is a medicine which has been authorized recently for treating psoriatic arthritis. It belongs to a family of medications known as "biologics." These act on a portion of the immune system, blocking the immune system response and lessening the autoimmune disease or another immune disease, such as rheumatoid arthritis. Humira is somewhat related to Enbrel, a commonly used treatment for both rheumatoid arthritis and psoriatic arthritis.
In a recent study on psoriasis patients, every other week, patients were injected Humira for a total of 24 weeks (twelve to thirteen doses total). Of those offered Humira, 42 percent of those with moderate to severe psoriasis had a ninety percent or better improvement in their psoriasis. About 65 percent of patients showed a 75...